Blonder Tongue Laboratories, Inc.: Blonder Tongue Reports Fo

Blonder Tongue Laboratories, Inc.: Blonder Tongue Reports Fourth Quarter and Year End 2020 Results


Blonder Tongue Laboratories, Inc.: Blonder Tongue Reports Fourth Quarter and Year End 2020 Results
BDR) announced its sales and results for the fourth quarter and year ended December 31, 2020.
Commenting on the year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, "Faced with a very difficult pandemic affected marketplace in 2020, the Company focused the year on completing a number of major organizational changes, R&D and intellectual property (IP) investments, product development, and inventory reduction programs. The acceleration of our operational restructuring in 2020 was completed along with streamlining both our manufacturing and engineering processes. The net result has been a lowering of the Company's operating costs by approximately $940,000 during 2020 versus 2019 and additional reductions that have been implemented in Q1 2021. The Company's operating expenses are now reduced by approximately $192,000 per month vs. one year ago. Our initiatives to complete IP investments yielded the Company several patent grants in 2020 covering our flagship NXG Digital Video Signal Processing platform and our DOCSIS data delivery product lines. Our 2020 product development initiatives completed over 15 new product introductions added to our portfolio in the areas of content security technology, high-speed data delivery, video transcoding, HEVC/H.265 and 4K/UHD codec support, and products associated with Tier 1 service operator requirements. We also completed a number of targeted product cost reductions with a goal of future margin improvements. Being the fortunate recipient in April 2020 of a CARES Act PPP federally-backed loan of $1,769,000, along with our inventory reduction program that improved the Company's cash used in operating activities by $4,421,000 last year, together enabled the Company to complete substantial organizational changes that carried one-time costs of approximately $220,000 and enabled us to carry the costs of our major IP investments, engineering and product development initiatives. The Company additionally directed sales efforts towards expanding direct Telco, Cable and Fiber Optics based service operator relationships which saw an increase of over 35% year on year, as well as the Company adding four new integrator and distributor relationships during 2020. Although the first quarter of 2021 has presented some of the same challenges as 2020, all of these investment decisions in 2020 have been designed to prepare the Company to emerge from the COVID- induced pandemic stronger and better prepared for growth opportunities throughout the remainder of 2021 and beyond."

Related Keywords

United States , Canada , New Jersey , American , Ted Grauch , Eric Skolnik , Exchange Commission , Going Concern Although The Company , Blonder Tongue Laboratories Inc , Midcap Business Credit , Blonder Tongue Laboratories , Chief Executive Officer Ted Grauch , Video Signal Processing , Fiber Optics , Tongue Laboratories , Midcap Facility , Annual Report , Paragraph Going Concern , Related Informationon , Blonder Tongue Investor Relations , Tongue Labs , Private Securities Litigation Reform Act , Blonder Tongue , Risk Factors , Legal Proceedings , Financial Condition , Consolidated Summary , Blonder , Tongue , Laboratories , Reports , Fourth , Quarter , Year , 2020 , Results , ஒன்றுபட்டது மாநிலங்களில் , கனடா , புதியது ஜெர்சி , அமெரிக்கன் , எரிக் ச்கொல்நீக் , பரிமாற்றம் தரகு , பொன்னிற நாக்கு ஆய்வகங்கள் இன்க் , பொன்னிற நாக்கு ஆய்வகங்கள் , காணொளி சமிக்ஞை ப்ரோஸெஸிஂக் , ஃபைபர் ஒளியியல் , நாக்கு ஆய்வகங்கள் , ஆண்டு அறிக்கை , பத்தி போகிறது அக்கறை , பொன்னிற நாக்கு முதலீட்டாளர் உறவுகள் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , பொன்னிற நாக்கு , ஆபத்து காரணிகள் , நிதி நிலை , தொகுக்கப்பட்டு சுருக்கம் , பொன்னிற , நாக்கு , ஆய்வகங்கள் , அறிக்கைகள் , நான்காவது , காலாண்டு , ஆண்டு , முடிவுகள் ,

© 2025 Vimarsana